TY - JOUR
T1 - Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
AU - Yamanishi, Yoshihiro
AU - Araki, Michihiro
AU - Gutteridge, Alex
AU - Honda, Wataru
AU - Kanehisa, Minoru
N1 - Funding Information:
Funding: This work was supported by the 21st Century COE program ‘Genome Science’ from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Institute for Bioinformatics Research and Development of the Japan Science and Technology Agency, and the Japan Society for the Promotion Science. The Computational resource was provided by the Bioinformatics Center, Institute for Chemical Research and the Super Computer Laboratory, Kyoto University and the Super Computer System, Human Genome Center, Institute of Medical Science, The University of Tokyo.
PY - 2008/7
Y1 - 2008/7
N2 - Motivation: The identification of interactions between drugs and target proteins is a key area in genomic drug discovery. Therefore, there is a strong incentive to develop new methods capable of detecting these potential drug-target interactions efficiently. Results: In this article, we characterize four classes of drug-target interaction networks in humans involving enzymes, ion channels, G-protein-coupled receptors (GPCRs) and nuclear receptors, and reveal significant correlations between drug structure similarity, target sequence similarity and the drug-target interaction network topology. We then develop new statistical methods to predict unknown drug-target interaction networks from chemical structure and genomic sequence information simultaneously on a large scale. The originality of the proposed method lies in the formalization of the drug-target interaction inference as a supervised learning problem for a bipartite graph, the lack of need for 3D structure information of the target proteins, and in the integration of chemical and genomic spaces into a unified space that we call 'pharmacological space'. In the results, we demonstrate the usefulness of our proposed method for the prediction of the four classes of drug-target interaction networks. Our comprehensively predicted drug-target interaction networks enable us to suggest many potential drug-target interactions and to increase research productivity toward genomic drug discovery.
AB - Motivation: The identification of interactions between drugs and target proteins is a key area in genomic drug discovery. Therefore, there is a strong incentive to develop new methods capable of detecting these potential drug-target interactions efficiently. Results: In this article, we characterize four classes of drug-target interaction networks in humans involving enzymes, ion channels, G-protein-coupled receptors (GPCRs) and nuclear receptors, and reveal significant correlations between drug structure similarity, target sequence similarity and the drug-target interaction network topology. We then develop new statistical methods to predict unknown drug-target interaction networks from chemical structure and genomic sequence information simultaneously on a large scale. The originality of the proposed method lies in the formalization of the drug-target interaction inference as a supervised learning problem for a bipartite graph, the lack of need for 3D structure information of the target proteins, and in the integration of chemical and genomic spaces into a unified space that we call 'pharmacological space'. In the results, we demonstrate the usefulness of our proposed method for the prediction of the four classes of drug-target interaction networks. Our comprehensively predicted drug-target interaction networks enable us to suggest many potential drug-target interactions and to increase research productivity toward genomic drug discovery.
UR - http://www.scopus.com/inward/record.url?scp=46249090791&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46249090791&partnerID=8YFLogxK
U2 - 10.1093/bioinformatics/btn162
DO - 10.1093/bioinformatics/btn162
M3 - Article
C2 - 18586719
AN - SCOPUS:46249090791
SN - 1367-4803
VL - 24
SP - i232-i240
JO - Bioinformatics
JF - Bioinformatics
IS - 13
ER -